Mertk
−/− mice are viable, but show retinal degeneration, because of the failure of the retinal pigment epithelium to engulf the outer segments of photoreceptors. 7, 11 MERTK also plays a pivotal role in atherosclerotic plaque development via its effects on efferocytosis: Mertk deficiency in Apoe −/− mice promotes accumulation of apoptotic cells and expansion of necrotic cores within plaques 12 ; and low-density lipoprotein receptor-deficient (Ldlr −/− ) mice with Mertk −/− bone marrow show accumulation of apoptotic cells and accelerated atherosclerosis. 13 In this study, we have generated and studied a mouse line, Aath4a DBA/DBA , in which a 5′ region of the Aath4 from DBA/2J has been transferred onto a 129S6-Apoe −/− background. We show that these mice have elevated plaque susceptibility and reduced efferocytosis by macrophages. We also demonstrate that decreased transcription of Mertk, not DBA-unique amino acid alterations in MERTK, determines the limited efferocytosis that occurs in Aath4a DBA/DBA mice.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Generation of Aath4a DBA/DBA Mice Aath4a DBA/DBA congenic mice were constructed by backcrossing DBA/2J-Apoe −/− mice to the 129S6-Apoe −/− strain for more than 7 generations. The backcrossed genomic segments in chromosome 2 (117-137 Mb) are shown in Figure 1A . The DBA allele of SNP (single nucleotide polymorphism) rs27446327 was used as a marker for Chr 2: 128 Mb. Heterozygous mice were mated to generate homozygotes. SNPs rs30884601, rs36935260, rs48427643, and rs30243498 were also typed at early generations to ensure that DBA alleles at other atherosclerosis QTLs (Chr 1: 155 Mb, Chr 1: 165 Mb, Chr 2: 143 Mb, and Chr 10: 86 Mb) were eliminated.
Aath4a
DBA/DBA Male Mice Develop Larger Plaques With Increased Calcium Deposits
As summarized in Table 1, Aath4a 129/129 control mice and Aath4a DBA/DBA mice showed no significant differences in body weight. In males, plasma cholesterol levels were almost the same between controls and Aath4a
DBA/DBA
, whereas triglycerides were significantly higher in Aath4a DBA/DBA (P=0.002). In female Aath4a
DBA/DBA mice, plasma total cholesterol was lower (P=0.010) and HDL-cholesterol was higher (P=0.016) compared with Aath4a 129/129 controls, but triglycerides were not significantly different.
At 5 months of age, Aath4a DBA/DBA male mice developed ≈50% larger plaques at the inner curve of the aortic arch compared with control mice (P<0.05; Figure 1B, Figure 1B , right). In contrast, females did not show significant differences in the size of either aortic arch or aortic root plaques. Male Aath4a DBA/DBA mice also developed significantly larger brachiocephalic artery lesions compared with the control (P<0.05), but did not differ in the left common carotid and left subclavian arteries. In females, no significant difference was observed in any of these branches between Aath4a DBA/DBA mice and controls ( Figure I in the online-only Data Supplement).
The plaques developing in the aortic roots of Aath4a DBA/DBA and control mice ranged from a monolayer of foam cells to complex lesions with inflammation and necrotic cores ( Figure  2A ; Figure II in the online-only Data Supplement). When plaques of similar size and locations were examined histologically, the early raised lesions of Aath4a DBA/DBA contained more scattered basophilic calcium deposits (Figure 2A 
Aath4a
DBA/DBA than in control mice ( Figure 2C ). Fibrous cap thickness was variable, and the difference was not statistically significant between the 2 groups ( Figure 2D ). However, collagen content in these lesions was less in the Aath4a DBA/DBA mice, suggesting that resolution of inflammation associated with the plaque development is likely delayed in Aath4a DBA/DBA ( Figure 2E ). General inflammation in these mice was low, judged by the low concentration of transforming growth factor-β1 and undetectable interleukin-10 in plasma. No significant differences in mRNA levels of interleukin-1β and transforming growth factor-β1 in the aorta were observed between control Aath4a 129/129 and Aath4a DBA/DBA mice or in plasma transforming growth factor-β1 levels ( Figure IVA and IVB in the online-only Data Supplement), probably because these mice were fed with normal chow.
Together these results indicate that the DBA/2J allele of the 5′ region of Aath4 enhances atherosclerosis in both the aortic arch and the root. Increased cell death in the early stages of plaque development may be associated with this enhancement.
Reduced Mertk Expression in

Aath4a
DBA/DBA Macrophages
The Aath4a QTL includes Mertk, which is important for efferocytosis, the phagocytotic removal of apoptotic cells. 4 MERTK is localized on cell surface where it is proteolytically cleaved by ADAM metallopeptidase domain 17 (ADAM17) to produce soluble MER (sMER). sMER attenuates MERTKtriggered intracellular signaling by blocking bridging molecules. 14 In thioglycollate-elicited peritoneal macrophages isolated from Aath4a DBA/DBA , Mertk mRNA levels were less than 50% of that in Aath4a 129/129 control macrophages ( Figure  3A ). In parallel with the mRNA expression, the amount of MERTK protein in cultured macrophages was also reduced in Aath4a DBA/DBA ( Figure 3B ), as well as cell-surface expression of MERTK ( Figure 3C) . sMER in the conditioned medium of Aath4a DBA/DBA macrophage and plasma sMER in Aath4a DBA/DBA mice were also reduced compared with those in controls, consistent with the reduction of protein amounts in macrophages ( Figure 3B and 3D). MERTK protein was abundantly present within the atherosclerotic plaques of the Aath4a 129/129 control mice, bordering the macrophage marker CD68-positive area, whereas the amount was significantly decreased in Aath4a DBA/DBA plaques (Figure V in the online-only Data Supplement).
Reduced Phagocytosis in Aath4a
DBA/DBA Macrophages MERTK is important for the normal execution of efferocytosis during atherosclerotic plaque development. 12, 13 We, therefore, examined phagocytosis of apoptotic Jurkat T cells by peritoneal macrophages of Aath4a DBA/DBA mice and found that the uptake of apoptotic cells was reduced to ≈40% of Aath4a Ghosn et al 15 have reported that there are two types of peritoneal macrophages: large peritoneal macrophages (LPMs) and small peritoneal macrophages (SPMs). 16 LPMs predominate in the steady state peritoneal cavity but are decreased by inflammatory stimuli such as lipopolysaccharide and Figure 5A and 5B). Both SPMs and LPMs express MERTK, although in Aath4a DBA/DBA macrophages, MERTK was markedly reduced in both SPMs and LPMs ( Figure 5C ). Consistent with a previous report, phagocytosis was higher in LPMs than in SPMs, 17 but importantly, both LPMs and SPMs showed similarly reduced phagocytosis in Aath4a DBA/DBA macrophages ( Figure 5D ).
MERTK Amino Acid Differences Do Not Affect Efferocytosis
There are 9 amino acid substitutions between 129S6 and DBA/2J MERTK, 3 of which (W25G, T80E, and S479R) are predicted to potentially alter protein function ( Figure 6A ). 4 The S479R substitution located adjacent to the ADAM17 cleavage site does not seem to have a significant effect on the shedding of MERTK because the proportion of sMER:MER was not altered between control and Aath4a DBA/DBA macrophages ( Figure 3B ). Likewise, when plasmids carrying Mertk cDNA of 129S6 or DBA/2J were transfected into HEK293T (human embryonic kidney 293T) cells, MERTK protein expression was similar, and comparable amounts of sMER were detected in the respective culture medium ( Figure 6B ). These results suggest that W25G, which is located close to the cleavage site of the secretion signal peptide, does not affect the protein maturation process.
We next examined the ability of the HEK293T cells expressing MERTK to phagocytose apoptotic Jurkat T cells. Overexpression of MERTK increased phagocytosis of apoptotic Jurkat T cells compared with the empty vector-transfected control cells, but no significant difference was observed between the 129S6 and the DBA/2J (empty vectors: 0.8±0.5%, 129S6-MERTK:
28.4±1.5%, and DBA/2J-MERTK: 29.5±1.5%; Figure 6C ). Addition of protein S, which bridges apoptotic cells and MERTK, stimulated phagocytosis in all of them, but a genetic effect was not observed (empty vectors: 4.1±1.6%, 129S6-MERTK: 45.3±1.5%, and DBA/2J-MERTK: 48.7±2.7%; Figure 6C ). Thus, the T80E substitution in the first immunoglobulin-like domain, which contains a ligand binding site, does not affect the binding to bridging protein S. These results indicate that the DBA/2J-specific amino acid substitutions in MERTK do not affect phagocytotic function.
Differences in Mertk Expression Levels Modulate Efferocytosis
Previous works have shown that mice lacking Mertk and Apoe (Mertk ) mice. We found that Mertk heterozygous macrophages, which are supposed to express 50% of MERTK, show ≈70% phagocytosis compared with wild-type macrophages (P=0.002; Figure 6D ), indicating that the amount of MERTK modulates efficiency of phagocytosis.
In agreement, when the amount of Mertk-plasmid transfected to HEK293 cells was gradually decreased, cell surface 129-MERTK and DBA-MERTK and phagocytosis were equally reduced ( Figure 6E ). We conclude that the amount of MERTK determines the efficiency of phagocytosis in a dosedependent, not an all-or-none manner, and that decreased Mertk expression in Aath4a DBA/DBA macrophages is the cause of the reduced phagocytosis.
Transcription Activity of the Proximal Promoter Region of Mertk
There are a large number of nucleotide polymorphisms throughout the Mertk gene, which could affect steady state levels of mRNA by affecting its stability. Accordingly, to clarify the cause of reduced To test whether the sequence differences in the proximal promoter region of Mertk affect the transcription level, we compared promoter activity of 129S6 and DBA/2J by a luciferase reporter assay. Mertk promoters of both 129S6 and DBA/2J enhanced luciferase expression in HEK293T cells ≈5× compared with empty vector, but the transcription activities of the Mertk promoter from 129S6 and DBA/2J were not significantly different ( Figure VIIIB in the onlineonly Data Supplement). Furthermore, addition of factors that are thought to regulate Mertk expression 18 including granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interleukin-4 did not significantly change the promoter activities ( Figure VIIIC in the online-only Data Supplement). Our experiments suggest that the genomic variants affecting the expression of Mertk must reside outside of this proximal 1.1 kb promoter region.
Indeed, when we searched for eQTLs associated with the expression levels of Mertk from Hybrid Mouse Diversity Panel by UCLA (https://systems.genetics.ucla.edu/data/hmdp), 19 more than 15 SNPs within the Aath4a interval were significantly associated with Mertk expression levels ( Table I in 129 and B6 but unique in DBA, and located between 63 kb and 2.6 Mb upstream of the Mertk gene, seem to regulate its expression in the liver and adipose tissue, whereas SNPs located between 2.3 and 2.5 Mb downstream were broadly associated with the expression levels in macrophages (Table  I in the online-only Data Supplement). Two SNPs at −325 and −202 kb upstream also showed strong association with the Mertk expression in macrophages, but 129 and DBA share the same variants at these positions. Together, it is likely that distant genetic variants affect the expression of Mertk.
Discussion
Each QTL identified in the crosses of inbred mice generally spans a large genomic distance, sometimes almost an entire chromosome. In complex phenotypes such as atherosclerosis, where a large number of genes are involved, transferring a target region onto an inbred background and creating congenic line is a powerful step toward identifying causative genes. Here we have analyzed the effect of the atherosclerosis QTL Aath4 by establishing a congenic line (Aath4a
DBA/DBA
), where the 5′ region of DBA Aath4 was backcrossed onto a 129S6-Apoe −/− background. As expected, the resulting Aath4a DBA/DBA males had significantly larger plaques, and macrophages isolated from these mice exhibited reduced efferocytosis as a consequence of allele-specific decrease in MERTK expression. Together, our results provide strong evidence that the increased susceptibility to atherosclerosis determined by the DBA allele of Aath4 is, at least in part, due to decreased MERTK expression.
MERTK is known to play a significant role in efferocytosis and the resolution of inflammation during atherosclerosis. 12, 13 In this report, we have demonstrated that 9 nonsynonymous SNPs in Mertk, which are uniquely different in DBA/2J compared with C57BL/6J and 129S6, are not responsible for the reduced efferocytosis observed in peritoneal macrophages from Aath4a DBA/DBA . Notably, our experiments demonstrated that the level of MERTK expression controls phagocytosis in Mertk +/− and Aath4a DBA/ DBA macrophages in a dose-dependent, not an all-or-none manner. This is consistent with many published reports that diseaserelated SNPs identified by GWAS (genome-wide association study) are usually located in introns or intergene regions rather than in coding sequences. Unlike diseases in which mutations in a single gene cause a drastic phenotype, the pathogenesis of atherosclerosis is more complex and involves numerous factors. SNPs or other alterations in regulatory regions typically lead to small changes in gene expression, which cumulatively influence susceptibility to disease. Our experiments show that Mertk expression is likely reduced at the transcription level because the stability of Mertk mRNA was unchanged in the Aath4a DBA/DBA macrophages. Furthermore, our reporter assay tests show that the genetic differences that cause different Mertk expression in DBA/2J and 129S6 are likely to be outside the proximal 1.1 kb promoter region, and search of eQTL database suggests that the expression of Mertk is affected by distant genetic variants. In humans, an SNP rs869016 in intron 1 of MERTK is associated with decreased risk of carotid atherosclerosis, although it is unknown whether the SNP modulates Mertk mRNA expression. 20 Further investigation of the causative variants is clearly required.
Efferocytosis, the phagocytosis of apoptotic cells by macrophages, is critical in preventing progression of atherosclerosis. 21 . This is because mice were fed with normal chow to eliminate additional effects caused by high-fat diet, and most of the lesions we observed were at their early stages. However, the calcium deposits are likely the remnants of dead/dying cells via apoptotic and necrotic processes, giving strong evidence that the normal process of removing dead cells is restricted in the Aath4a DBA/DBA mice. Delayed apoptotic cell clearance is expected to cause acceleration of plaque development and necrotic core formation. The calcium deposits in the early plaques, however, seem to be shortlived because larger calcified areas in advanced Aath4a DBA/DBA plaques are not different from the control plaques and are seen mostly deeper in the intima near the internal elastic lamina. Although the thickness of fibrous caps was not significantly different, the Aath4a DBA/DBA plaques contained less interstitial matrix proteins than similar-sized plaques in the control mice. In advanced plaques, efferocytosis by macrophages becomes less effective than in early plaques, but an alteration in the balance between synthesis and degradation of matrix protein would be expected to contribute to vulnerable plaque morphology. Although we have not encountered any premature deaths associated with the Aath4a DBA/DBA mice, a more detailed examination of later stage plaques would be worthwhile.
Despite the well-known heterogeneity of mouse peritoneal macrophages, 15, 16 we found that MERTK is expressed in both LPMs and SPMs, and that it is similarly reduced in both populations of Aath4a DBA/DBA macrophages. We also observed that the LPMs, which have higher phagocytic activity than SPMs, 17 were consistently fewer in Aath4a DBA/DBA than in controls. Fewer LPMs and more SPMs could be another factor contributing to the reduced phagocytosis in Aath4a DBA/DBA peritoneal macrophages. SPMs are induced from circulating monocytes by inflammatory stimuli, whereas LPMs are thought to be tissue-resident macrophages, maintained locally by differentiation from precursor cells. Macrophages in atherosclerotic plaques are similarly heterogeneous, 22, 23 and the role of circulating monocyte-derived macrophages in the development of plaques has been well-documented. Evidence is also beginning to accumulate that tissue-resident macrophages originating from the adventitial precursor cells contribute to atherogenesis. Factors that control the relative balance of these populations are not known, but a shift in the population of the Aath4a DBA/DBA macrophages in their plaques is conceivable. Whether MERTK expression directly affects this shift or not requires further study.
Although we identified Aath4 as a QTL specific to the arch lesion, the Aath4a DBA/DBA mice have significantly larger plaques in both the aortic arch and the root. This is in agreement with our prediction that the reduced efferocytosis of Aath4a DBA/DBA macrophages should equally affect both the aortic arch and the e90 Arterioscler Thromb Vasc Biol July 2017 root. Our previous studies of F2 population between 129S6-Apoe −/− and C57BL/6-Apoe −/− indicated that 129S6 genome carries the sequence that affects the aortic arch geometry, which are also associated with increased aortic arch atherosclerosis. 2 Therefore, the variant in Mertk expression is a risk factor that is additional to the 129S6 sequences that determine the aortic arch development because the Aath4a DBA/DBA strain is based upon the129S6 genome. Moreover, the contribution of Mertk expression to the 50% increase in root lesion is, although significant, relatively small, considering that the parental DBA/2J show 10× larger plaques in the root than 129S6 mice.
The genomic region of DBA/2J carried in the Aath4a DBA/DBA mice is large, and the effect of DNA variants in other locations in this region must be considered. For example, Siglec1 at 131 Mb, which encodes sialoadhesin (CD169), is involved in the retention of hematopoietic stem cells in the bone marrow niche. 24 It is also expressed in a subset of tissue-resident macrophages, preventing excessive inflammation upon injury. 25 Similarly, CD169 may also play a role in phagocytosis. 26, 27 Altered expression of Bcl2l11 at 128 Mb, encoding for a proapoptotic protein Bim, could affect early cell death in the Aath4a DBA/DBA plaques. In addition, as the backcrossed region in the Aath4a DBA/DBA line is the proximal half of Aath4, the distal half may include genes that are proatherogenic only in the arch, or are athero-suppressive specifically in the root. One of the candidates in distal Aath4 is Cd93 at 148 Mb, a transmembrane glycoprotein which is expressed in endothelial and myeloid cells. CD93-deficient mice show a defect in the clearance of apoptotic cells in vivo, 28 and an SNP in Cd93 gene is associated with an increased risk of coronary heart disease. 29 Analysis of a congenic line carrying the distal half of Aath4 of DBA/2J is currently under way.
We also note that the plaque size difference was observed only in Aath4a DBA/DBA males, whereas the male/female differences in plaque size were not seen in the parental strains: DBA/2J-Apoe −/− mice show larger root lesions compared with 129S6-Apoe −/− in both males and females 3 ; arch lesion size was comparable between the 2 strains in both males and females. 4 The QTLs on Chr 2 were detected in both males and females in the F2 population from DBA/2J-Apoe −/− and 129S6-Apoe −/− mice. 3, 4 Because no QTL was detected on Chr 2 for plasma lipids in the intercross between the 2 strains, the plasma lipid differences between males and females are not likely the strong determinant of the plaque size differences. 3 The major determinants for the plaque sizes in females must, therefore, lie outside of the Aath4a interval. The sex dimorphism in the Aath4a DBA/DBA mice requires further investigation. In summary, our experiments have shown that the DBA allele of the 5′ region of Aath4 causes inefficient efferocytosis via lower expression of MERTK, and that difference contributes to the enhanced plaque development observed in Aath4a DBA/DBA mice. Because the effects of reduced MERTK and efferocytosis are seen in the both aortic arch and root areas, further studies will be required to fully understand the factors that cause location specificity in atherosclerosis.
